ELOX
|Eloxx Pharmaceuticals Inc
PINK
USD 0.00
|%
Current Price
USD 0.00
Change
(%)
P/E Ratio
Dividend Yield
Market Cap
314
Volume
3,232
Open
USD 0.00
Previous Close
USD 0.00
52-Week High
USD 0.90
52-Week Low
USD 0.00
About Eloxx Pharmaceuticals Inc
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrop...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Sumit Aggarwal M.B.A.
Employees:18
Headquarters:Watertown, USA
Website:www.eloxxpharma.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions